Copyright Reports & Markets. All rights reserved.

Global Risperidone Market Research Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Risperidone Market Overview

      • 1.1 Product Overview and Scope of Risperidone
      • 1.2 Risperidone Segment by Type
        • 1.2.1 Global Risperidone Production Growth Rate Comparison by Type (2014-2025)
        • 1.2.2 Oral
        • 1.2.3 Injectable
      • 1.3 Risperidone Segment by Application
        • 1.3.1 Risperidone Consumption Comparison by Application (2014-2025)
        • 1.3.2 Schizophrenia
        • 1.3.3 Bipolar Disorder
      • 1.3 Global Risperidone Market by Region
        • 1.3.1 Global Risperidone Market Size Region
        • 1.3.2 North America Status and Prospect (2014-2025)
        • 1.3.3 Europe Status and Prospect (2014-2025)
        • 1.3.4 China Status and Prospect (2014-2025)
        • 1.3.5 Japan Status and Prospect (2014-2025)
        • 1.3.6 Southeast Asia Status and Prospect (2014-2025)
        • 1.3.7 India Status and Prospect (2014-2025)
      • 1.4 Global Risperidone Market Size
        • 1.4.1 Global Risperidone Revenue (2014-2025)
        • 1.4.2 Global Risperidone Production (2014-2025)

      2 Global Risperidone Market Competition by Manufacturers

      • 2.1 Global Risperidone Production Market Share by Manufacturers (2014-2019)
      • 2.2 Global Risperidone Revenue Share by Manufacturers (2014-2019)
      • 2.3 Global Risperidone Average Price by Manufacturers (2014-2019)
      • 2.4 Manufacturers Risperidone Production Sites, Area Served, Product Types
      • 2.5 Risperidone Market Competitive Situation and Trends
        • 2.5.1 Risperidone Market Concentration Rate
        • 2.5.2 Risperidone Market Share of Top 3 and Top 5 Manufacturers
        • 2.5.3 Mergers & Acquisitions, Expansion

      3 Global Risperidone Production Market Share by Regions

      • 3.1 Global Risperidone Production Market Share by Regions
      • 3.2 Global Risperidone Revenue Market Share by Regions (2014-2019)
      • 3.3 Global Risperidone Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.4 North America Risperidone Production
        • 3.4.1 North America Risperidone Production Growth Rate (2014-2019)
        • 3.4.2 North America Risperidone Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.5 Europe Risperidone Production
        • 3.5.1 Europe Risperidone Production Growth Rate (2014-2019)
        • 3.5.2 Europe Risperidone Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.6 China Risperidone Production (2014-2019)
        • 3.6.1 China Risperidone Production Growth Rate (2014-2019)
        • 3.6.2 China Risperidone Production, Revenue, Price and Gross Margin (2014-2019)
      • 3.7 Japan Risperidone Production (2014-2019)
        • 3.7.1 Japan Risperidone Production Growth Rate (2014-2019)
        • 3.7.2 Japan Risperidone Production, Revenue, Price and Gross Margin (2014-2019)

      4 Global Risperidone Consumption by Regions

      • 4.1 Global Risperidone Consumption by Regions
      • 4.2 North America Risperidone Consumption (2014-2019)
      • 4.3 Europe Risperidone Consumption (2014-2019)
      • 4.4 China Risperidone Consumption (2014-2019)
      • 4.5 Japan Risperidone Consumption (2014-2019)

      5 Global Risperidone Production, Revenue, Price Trend by Type

      • 5.1 Global Risperidone Production Market Share by Type (2014-2019)
      • 5.2 Global Risperidone Revenue Market Share by Type (2014-2019)
      • 5.3 Global Risperidone Price by Type (2014-2019)
      • 5.4 Global Risperidone Production Growth by Type (2014-2019)

      6 Global Risperidone Market Analysis by Applications

      • 6.1 Global Risperidone Consumption Market Share by Application (2014-2019)
      • 6.2 Global Risperidone Consumption Growth Rate by Application (2014-2019)

      7 Company Profiles and Key Figures in Risperidone Business

      • 7.1 Janssen Pharmaceutica
        • 7.1.1 Janssen Pharmaceutica Risperidone Production Sites and Area Served
        • 7.1.2 Risperidone Product Introduction, Application and Specification
        • 7.1.3 Janssen Pharmaceutica Risperidone Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.1.4 Main Business and Markets Served
      • 7.2 Teva
        • 7.2.1 Teva Risperidone Production Sites and Area Served
        • 7.2.2 Risperidone Product Introduction, Application and Specification
        • 7.2.3 Teva Risperidone Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.2.4 Main Business and Markets Served
      • 7.3 Sun Pharmaceutical
        • 7.3.1 Sun Pharmaceutical Risperidone Production Sites and Area Served
        • 7.3.2 Risperidone Product Introduction, Application and Specification
        • 7.3.3 Sun Pharmaceutical Risperidone Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.3.4 Main Business and Markets Served
      • 7.4 Aurobindo
        • 7.4.1 Aurobindo Risperidone Production Sites and Area Served
        • 7.4.2 Risperidone Product Introduction, Application and Specification
        • 7.4.3 Aurobindo Risperidone Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.4.4 Main Business and Markets Served
      • 7.5 Cipla
        • 7.5.1 Cipla Risperidone Production Sites and Area Served
        • 7.5.2 Risperidone Product Introduction, Application and Specification
        • 7.5.3 Cipla Risperidone Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.5.4 Main Business and Markets Served
      • 7.6 Invent Farma Group
        • 7.6.1 Invent Farma Group Risperidone Production Sites and Area Served
        • 7.6.2 Risperidone Product Introduction, Application and Specification
        • 7.6.3 Invent Farma Group Risperidone Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.6.4 Main Business and Markets Served
      • 7.7 Medichem
        • 7.7.1 Medichem Risperidone Production Sites and Area Served
        • 7.7.2 Risperidone Product Introduction, Application and Specification
        • 7.7.3 Medichem Risperidone Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.7.4 Main Business and Markets Served
      • 7.8 Interquim
        • 7.8.1 Interquim Risperidone Production Sites and Area Served
        • 7.8.2 Risperidone Product Introduction, Application and Specification
        • 7.8.3 Interquim Risperidone Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.8.4 Main Business and Markets Served
      • 7.9 IPCA
        • 7.9.1 IPCA Risperidone Production Sites and Area Served
        • 7.9.2 Risperidone Product Introduction, Application and Specification
        • 7.9.3 IPCA Risperidone Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.9.4 Main Business and Markets Served
      • 7.10 RPG
        • 7.10.1 RPG Risperidone Production Sites and Area Served
        • 7.10.2 Risperidone Product Introduction, Application and Specification
        • 7.10.3 RPG Risperidone Production, Revenue, Price and Gross Margin (2014-2019)
        • 7.10.4 Main Business and Markets Served
      • 7.11 Sharon
      • 7.12 Torrent Pharmaceuticals
      • 7.13 Temad
      • 7.14 Wuxi Jida
      • 7.15 Changzhou Siyao Pharmaceuticals
      • 7.16 Ningbo Team Pharm
      • 7.17 Zhejiang Huahai Pharmaceutical
      • 7.18 TIPR
      • 7.19 Qilu Pharmaceutical

      8 Risperidone Manufacturing Cost Analysis

      • 8.1 Risperidone Key Raw Materials Analysis
        • 8.1.1 Key Raw Materials
        • 8.1.2 Price Trend of Key Raw Materials
        • 8.1.3 Key Suppliers of Raw Materials
      • 8.2 Proportion of Manufacturing Cost Structure
      • 8.3 Manufacturing Process Analysis of Risperidone
      • 8.4 Risperidone Industrial Chain Analysis

      9 Marketing Channel, Distributors and Customers

      • 9.1 Marketing Channel
        • 9.1.1 Direct Marketing
        • 9.1.2 Indirect Marketing
      • 9.2 Risperidone Distributors List
      • 9.3 Risperidone Customers

      10 Market Dynamics

      • 10.1 Market Trends
      • 10.2 Opportunities
      • 10.3 Market Drivers
      • 10.4 Challenges
      • 10.5 Influence Factors

      11 Global Risperidone Market Forecast

      • 11.1 Global Risperidone Production, Revenue Forecast
        • 11.1.1 Global Risperidone Production Growth Rate Forecast (2019-2025)
        • 11.1.2 Global Risperidone Revenue and Growth Rate Forecast (2019-2025)
        • 11.1.3 Global Risperidone Price and Trend Forecast (2019-2025)
      • 11.2 Global Risperidone Production Forecast by Regions (2019-2025)
        • 11.2.1 North America Risperidone Production, Revenue Forecast (2019-2025)
        • 11.2.2 Europe Risperidone Production, Revenue Forecast (2019-2025)
        • 11.2.3 China Risperidone Production, Revenue Forecast (2019-2025)
        • 11.2.4 Japan Risperidone Production, Revenue Forecast (2019-2025)
      • 11.3 Global Risperidone Consumption Forecast by Regions (2019-2025)
        • 11.3.1 North America Risperidone Consumption Forecast (2019-2025)
        • 11.3.2 Europe Risperidone Consumption Forecast (2019-2025)
        • 11.3.3 China Risperidone Consumption Forecast (2019-2025)
        • 11.3.4 Japan Risperidone Consumption Forecast (2019-2025)
      • 11.4 Global Risperidone Production, Revenue and Price Forecast by Type (2019-2025)
      • 11.5 Global Risperidone Consumption Forecast by Application (2019-2025)

      12 Research Findings and Conclusion

        13 Methodology and Data Source

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        The global Risperidone market is valued at million US$ in 2018 is expected to reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
        This report focuses on Risperidone volume and value at global level, regional level and company level. From a global perspective, this report represents overall Risperidone market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
        At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

        The following manufacturers are covered:
        Janssen Pharmaceutica
        Teva
        Sun Pharmaceutical
        Aurobindo
        Cipla
        Invent Farma Group
        Medichem
        Interquim
        IPCA
        RPG
        Sharon
        Torrent Pharmaceuticals
        Temad
        Wuxi Jida
        Changzhou Siyao Pharmaceuticals
        Ningbo Team Pharm
        Zhejiang Huahai Pharmaceutical
        TIPR
        Qilu Pharmaceutical

        Segment by Regions
        North America
        Europe
        China
        Japan

        Segment by Type
        Oral
        Injectable

        Segment by Application
        Schizophrenia
        Bipolar Disorder

        Buy now